Correlation of CD4 : CD8 ratio and tumour necrosis factor (TNF)alpha levels in induced sputum with bronchoalveolar lavage fluid in pulmonary sarcoidosis
Yp. Moodley et al., Correlation of CD4 : CD8 ratio and tumour necrosis factor (TNF)alpha levels in induced sputum with bronchoalveolar lavage fluid in pulmonary sarcoidosis, THORAX, 55(8), 2000, pp. 696-699
Background-An increased CD4:CD8 lymphocyte ratio and raised cytokine levels
in bronchoalveolar lavage (BAL) fluid are characteristic of pulmonary sarc
oidosis. Sputum induction has been used as a non-invasive tool for investig
ating the airways and may be useful in investigating inflammation in patien
ts with sarcoidosis in whom endobronchial, peribronchial, and parenchymal i
nflammation is present. This study aimed to correlate the total and differe
ntial cell counts, CD4:CD8 ratio, and tumour necrosis factor (TNF)alpha lev
els between induced sputum and BAL fluid in patients with pulmonary sarcoid
osis.
Methods-Fourteen patients with newly diagnosed biopsy proven sarcoidosis an
d six healthy controls were investigated. Sputum induction and BAL was carr
ied out at the initial visit and repeated following six months of treatment
with oral prednisone.
Results-There was no correlation of differential cell counts between induce
d sputum and BAL fluid. The CD4:CD8 ratio in induced sputum correlated stro
ngly with that in BAL fluid (5.5 (0.4:1) versus 4.4 (0.2:1); r = 0.8, p<0.0
01) and the fall in the ratio following six months of treatment in sputum p
aralleled that in BAL fluid (3.4 (0.2:1) versus 2.4 (0.2:1)). The TNF alpha
levels in sputum also correlated with levels in the BAL fluid (11.9 (1.5)
pg/ mi versus 17.6 (2.7) pg/ml; r = 0.8, p<0.001). The fall in sputum TNF a
lpha levels following six months of treatment paralleled the fall in BAL fl
uid levels (6.7 (0.9) pg/ml versus 11.6 (1.3) pg/ml).
Conclusions-The CD4:CD8 ratio and TNF alpha levels in induced sputum correl
ated with those in BAL fluid and paralleled changes with treatment. Induced
sputum may therefore be a non-invasive surrogate for certain parameters in
BAL fluid in patients with sarcoidosis.